Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer

被引：0
作者：
Suguru Yamada
Tsutomu Fujii
Yukihiro Yokoyama
Hiroki Kawashima
Osamu Maeda
Kojiro Suzuki
Tohru Okada
Eizaburo Ono
Junpei Yamaguchi
Nao Takano
Hideki Takami
Masamichi Hayashi
Yukiko Niwa
Yoshiki Hirooka
Yoshiyuki Ito
Shinji Naganawa
Yuichi Ando
Masato Nagino
Hidemi Goto
Yasuhiro Kodera
机构：
[1] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery (Surgery II)
[2] University of Toyama,Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Sciences
[3] Nagoya University Graduate School of Medicine,Division of Surgical Oncology, Department of Surgery
[4] Nagoya University Graduate School of Medicine,Department of Gastroenterology and Hepatology
[5] Nagoya University Hospital,Department of Clinical Oncology and Chemotherapy
[6] Aichi Medical University,Department of Radiology
[7] Nagoya University Graduate School of Medicine,Department of Radiology
[8] Nagoya University Hospital,Department of Endoscopy
来源：
Cancer Chemotherapy and Pharmacology | 2018年 / 81卷
关键词：
Phase I study; Gemcitabine; Nab-paclitaxel; Radiation; Unresectable locally advanced pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 821
页数：6
相关论文
共 50 条
[21]   Effectiveness and safety of nab-paclitaxel/gemcitabine in locally advanced or metastatic pancreatic adenocarcinoma [J].
Nebot-Villacampa, Maria-Jose ;
Zafra-Morales, Ricardo ;
Alfaro-Olea, Ascension ;
Marin-Gorricho, Raquel ;
Casajus-Navasal, Andrea ;
Uriarte-Pinto, Moises .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (03) :603-611
[22]   Gemcitabine plus nab-paclitaxel with initial dose reduction for older patients with advanced pancreatic cancer [J].
Ibusuki, Mayu ;
Inoue, Tadahisa ;
Kitano, Rena ;
Sakamoto, Kazumasa ;
Kimoto, Satoshi ;
Kobayashi, Yuji ;
Ohashi, Tomohiko ;
Sumida, Yoshio ;
Nakade, Yukiomi ;
Ito, Kiyoaki ;
Yoneda, Masashi .
JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (01) :118-121
[23]   Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinoma [J].
Rogers, Jane E. ;
Mizrahi, Jonathan D. ;
Xiao, Lianchun ;
Mohindroo, Chirayu ;
Shroff, Rachna T. ;
Wolff, Robert ;
Varadhachary, Gauri R. ;
Javle, Milind M. ;
Overman, Michael ;
Fogelman, David R. ;
Raghav, Kanwal P. S. ;
Pant, Shubham ;
McAllister, Florencia .
CANCER MEDICINE, 2020, 9 (15) :5406-5415
[24]   A Phase I Study of Gemcitabine/Nab-Paclitaxel/S-1 Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma [J].
Chang, Chen ;
Li, Xiaofen ;
Cheng, Ke ;
Cai, Zhaolun ;
Xiong, Junjie ;
Lv, Wanrui ;
Li, Ruizhen ;
Zhang, Pei ;
Cao, Dan .
ONCOLOGIST, 2023, 28 (07) :E575-E584
[25]   Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer [J].
Ueno, Hideki ;
Ikeda, Masafumi ;
Ueno, Makoto ;
Mizuno, Nobumasa ;
Ioka, Tatsuya ;
Omuro, Yasushi ;
Nakajima, Takako Eguchi ;
Furuse, Junji .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (03) :595-603
[26]   Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer [J].
Dong-sheng Zhang ;
De-shen Wang ;
Zhi-qiang Wang ;
Feng-hua Wang ;
Hui-yan Luo ;
Miao-zhen Qiu ;
Feng Wang ;
Yu-hong Li ;
Rui-hua Xu .
Cancer Chemotherapy and Pharmacology, 2013, 71 :1065-1072
[27]   Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer [J].
Shi, Zhan ;
Yang, Ju ;
Kong, Weiwei ;
Qiu, Xin ;
Lu, Changchang ;
Liu, Juan ;
Liu, Baorui ;
Du, Juan .
FRONTIERS IN ONCOLOGY, 2022, 12
[28]   Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX [J].
Peterson, Shawn L. ;
Husnain, Muhammad ;
Pollack, Terri ;
Pimentel, Agustin ;
Loaiza-Bonilla, Arturo ;
Westendorf-Overley, Colleen ;
Ratermann, Kelley ;
Anthony, Lowell ;
Desimone, Philip ;
Goel, Gaurav ;
Kudrimoti, Mahesh ;
Dineen, Sean ;
Tzeng, Ching-Wei D. ;
Hosein, Peter J. .
ANTICANCER RESEARCH, 2018, 38 (07) :4035-4039
[29]   A clinical trial to assess the feasibility and efficacy of nab-paclitaxel plus gemcitabine for elderly patients with unresectable advanced pancreatic cancer [J].
Rikiya Hasegawa ;
Kosuke Okuwaki ;
Mitsuhiro Kida ;
Hiroshi Yamauchi ;
Yusuke Kawaguchi ;
Takaaki Matsumoto ;
Toru Kaneko ;
Eiji Miyata ;
Kazuho Uehara ;
Tomohisa Iwai ;
Masafumi Watanabe ;
Takahiro Kurosu ;
Hiroshi Imaizumi ;
Takashi Ohno ;
Wasaburo Koizumi .
International Journal of Clinical Oncology, 2019, 24 :1574-1581
[30]   A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer [J].
Liu, Ting ;
Li, Qing ;
Lin, Zhen ;
Liu, Chunhua ;
Pu, Wei ;
Zeng, Shasha ;
Lai, Jun ;
Cai, Xuebin ;
Zhang, Lisha ;
Wang, Shuyang ;
Chen, Miao ;
Cao, Wei ;
Gou, Hongfeng ;
Zhu, Qing .
CANCER RESEARCH AND TREATMENT, 2024, 56 (02) :602-615
12345